Do ATG16L1 rs2241880 and TLR4 rs4986790 variants increase intestinal immune activation?

The maintenance of intestinal homeostasis relies on a precise balance between clearing intracellular microbes and modulating inflammatory responses to resident microflora. Genetic variations in key host-defense pathways can alter this immunological equilibrium.

Cellular and mechanistic alterations

• Impaired Autophagy and Xenophagy: The ATG16L1 rs2241880 (T300A) variant increases caspase-3/7-mediated cleavage of the ATG16L1 protein. This molecular defect leads to reduced autophagic flux and impaired selective antibacterial autophagy (xenophagy), which diminishes the host's capacity to clear intracellular bacteria.
• Blunted Endotoxin Signaling: The TLR4 rs4986790 (Asp299Gly) variant functions as a hypomorphic allele. Although lipopolysaccharide (LPS) binding is preserved, this variant compromises the recruitment of the crucial adapter proteins MyD88 and TRIF, blunting downstream NF-κB activation and cytokine production.

Impact on mucosal immune activation

• Loss of the Autophagic Brake: Autophagy serves as a critical negative regulator of toll-like receptor (TLR) signaling. Defective autophagy caused by the ATG16L1 variant removes this inhibitory feedback loop, rendering the host hyper-responsive to endotoxins. This loss of regulatory restraint leads to elevated NF-κB activation and increased secretion of pro-inflammatory cytokines, such as IL-1β.
• Altered Mucosal Inflammatory Tone: Altered endotoxin signaling via the hypomorphic TLR4 variant directly influences downstream tight junction regulation and cytokine profiles. When combined with defective autophagy, these convergent pathways lower the gut's threshold for mucosal immune activation and epithelial barrier disruption.

Bottom line

• The ATG16L1 rs2241880 and TLR4 rs4986790 variants alter intestinal homeostasis by disrupting bacterial clearance and endotoxin-sensing mechanisms. The loss of autophagic regulation hyper-sensitizes toll-like receptor pathways, lowering the threshold for mucosal immune activation and compromising epithelial barrier integrity.